Live Coverage from the GU Cancers ...

Check out our coverage of the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco, CA

Combo Superior for Advanced RCC

As first-line therapy for locally advanced or metastatic renal cell carcinoma, pembrolizumab plus axitinib offers longer overall and progression-free survival compared with sunitinib.

Improving Dialysis for Undocumented Immigrants

Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.

Abiraterone, Prednisone Efficacious in mCNPC

At a median follow-up of nearly 52 months, the treatment regimen deceased mortality risk among men with high-risk metastatic castration-naive prostate cancer by 30%.

Cancer Death Risk Up in Dialysis ...

Dialysis patients were more likely than transplant recipients to die from pre-existing cancers, whereas transplant recipients were more likely to die from de novo cancers.

Darolutamide Ups Survival in CRPC

Median metastasis-free survival was longer with darolutamide than with placebo: 40.4 vs 18.4 months.

Email Precautions Can Prevent Breaches

Staff at medical practices should be taught to recognize suspicious email messages

When Patients Refuse Treatment

Find Jobs

Check out Renal & Urology News' job board


Jan-Feb Digital Issue

CME Spotlight

Sign Up for Free e-newsletters